Transcriptome Analysis of the Effects of Gomisin A on the Recovery of Carbon Tetrachloride-Induced Damage in Rat Liver by Choi, Young Mi et al.
161
Transcriptome Analysis of the Effects of Gomisin A on the Recovery 
of Carbon Tetrachloride-Induced Damage in Rat Liver
Young Mi Choi
1, In Soo Choi
2, Sang Mong Lee
3, Dae Youn Hwang
4, Young Whan Choi
1, Young Hoon Park
1*
1Department of Horticultural Bioscience, College of Natural Resource & Life Science, Pusan National University,
Miryang, Republic of Korea
2Department of Plant Bioscience, College of Natural Resource & Life Science, Pusan National University, Miryang,
Republic of Korea
3Department of Life Science & Environmental Biochemistry, College of Natural Resource & Life Science,
Pusan National University, Miryang, Republic of Korea
4Department of Biomaterials Science, College of Natural Resource & Life Science, Pusan National University,
Miryang, Republic of Korea
Gomisin A possesses a hepatic function-facilitating property in liver-injured rats. Its preventive action on
carbon tetrachloride-induced cholestasis is due to maintenance of the function of the bile acids-
independent fraction. To investigate alterations in gene expression after gomisin A treatment on injured
rat liver, DNA microarray analyses were performed on a Rat 44K 4-Plex Gene Expression platform with
duplicated reactions after gomisin A treatment. We identified 255 up-regulated and 230 down-regulated
genes due to the effects of gomisin A on recovery of carbon tetrachloride-induced rat liver damage. For
functional characterization of these genes, Gene Ontology and Kyoto Encyclopedia of Genes and
Genomes biochemical pathways analyses were performed. Many up-regulated or down-regulated genes
were related to cell cycle or focal adhesion and cell death genes, respectively. Our microarray experiment
indicated that the liver repair mechanism induced by gomisin A was strongly associated with increased
gene expressions related to cell cycle and suppression of the gene expression related in cell death.
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Schisandra chinensis (Turcz.) Baill grows wild in the
easternmost parts of Russia, the Kuril islands, Southern Sachalin,
Northeastern China, Korea and Japan [1]. S. chinensis has
some beneficial effects, including hepatoprotective, antioxidative,
anti-inflammatory, anticancer, and anti-HIV actions. S.
chinensis has many active ligands, including gomisins A, B,
C, F, G, H, J, M and N, and schisandrin B and C [2]. These
ligands isolated from S. chinensis showed protective effects
from inflammatory infiltration and liver cell necrosis induced
by carbon tetrachloride (CCl4) [3], including acetaminophen-
induced hepatotoxicity and glutamate-induced oxidative
neuronal damage [4,5]. In particular, gomisin A has been
known to possess a liver function-facilitating property that
is related to preventive action on CCl4-induced fibrosis in
liver-injured rats by maintaining the function of the bile acids-
independent fraction [6]. In addition, gomisin A has been
reported to be effective in improving immunologically induced
acute hepatic failure [7], as well as in stimulating liver
regeneration after a partial hepatectomy [8].
Liver fibrosis is characterized by excessive deposition of
connective tissue and distortion. Many mediators are involved
in the process of fibrogenesis. Molecular mechanisms involved
in fibrogenesis revealed that transforming growth factor-β
(TGF-β) played a pivotal role, and depletion of fibrosis by
regulating the expression of TGF genes is expected to be
a new therapy for liver fibrosis. For example, taurine, heparin-
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superoxide dismutase conjugate, tetramethyl pyrazine,
imatinib mesylate, perindopril, and ginkgo biloba down-
regulated the TGF pathway [9-14]. These therapy molecules
protect the rat liver from fibrogenesis induced by CCl4, and
the possible mechanism could involve the down-regulation
of TGF-β.
As the human genome project has been completed,
attention is currently focused on understanding the gene
expression profiles of disease states in cells and tissues, as
well as the development of platform technology or
methodology for detecting and quantitating gene expression
levels. Northern blots, Southern blots, PCR, S1 nuclease
protection, differential display, cDNA library sequencing, and
serial analysis of gene expression (SAGE) methods have limited
ability to analyze a large amount of data quantitatively. The
DNA microarray system is one of the most powerful
technologies for analyzing gene expression in many fields
of biological research analyzing the expression profiles of
thousands of genes in a wide range of biological systems
[15-19]. This technology enables scientists to do a high-
sensitivity parallel screening of a large number of genes with
a small amount of starting material. Recently, the introduction
of fluorescent probes has made it possible to array tens of
thousands of short oligo-nucleotides representing the full
transcriptome of a species on a miniaturized slide-glass array
[20].
In the present work, we investigated the transcriptome profile
related to the hepatoprotective effects of gomisin A on CCL4-
induced rat liver damage. Using microarray technology, we
screened for genes differentially expressed after treatment
of gomisin A on rat livers that were damaged by CCl4. DNA
microarray-based gene profiling identified 255 up-regulated
genes and 230 down-regulated genes, and their specific
metabolic pathways were described.
Materials and Methods
Extraction and elucidation of gomisin A
The fruits of S. chinensis used in this study were collected
from Moongyeong, Korea in September, 2005. A voucher
specimen (accession No. SC-PNUNPRL-1) was deposited in
the Herbarium of Pusan National University. Pure gomisin
A was identified by high performance liquid chromatography
on a Phenomenex Luna C18 column (150×4.6 mm internal
diameter, 5-µm particle size; Phenomenex, Torrance, CA,
USA) [21]. The chemical structure of gomisin A used in this
study was verified by liquid chromatography-mass spectrometry
(LC-MS; Bruker BioApex FT Mass Spectrometer, Billerica, MA,
USA) and nuclear magnetic resonance (NMR) analysis (Varian
Inova 500 Spectrometer, Vernon Hills, IL, USA). Optical
rotations were recorded on a Jasco DIP-370 Digital polarimeter,
Essex, UK). IR spectra were recorded on an ATI Mattson
Genesis Series FTIR, Golden Valley, MN, USA). NMR spectra
(
1H, 
13C) were recorded in CDCl3 on a Varian Inova 500
Spectrometer operating at 500 MHz for 
1H and 125 MHz
for 
13C, running gradients and using residual solvent peaks
as internal references. High-resolution mass spectra were
recorded on a Bruker BioApex FT Mass Spectrometer.
Maintenance of rats
All subjects were female Sprague-Dawley (SD) rats,
purchased from Samtaco Biokorea (Osan, Korea). These rats
were kept in Pusan National University/Laboratory Animal
Resources Center in accordance with the US National Institute
of Health (NIH) Animal Care policies. The rats were given
a standard irradiated chow diet (Purina Mills, St. Louis, MO,
USA) ad libitum and were maintained in a specified pathogen-
free state under a strict light cycle (light on at 06:00 and
off at 18:00). Furthermore, the animal protocol used in this
study has been reviewed and approved by the Pusan National
University Institutional Animal Care and Use Committee (PNU-
IACUC).
Experimental design for gomisin A treatment
Eight-week-old SD rats were randomly divided into four
groups with five rats per group. The first group of SD rats
was not treated by any compounds as an untreated control
group (UT group), while the second group received 100 mg/
kg body weight per day of gomisin A via oral administration
for 4 days (gomisin A-treated group, GT group). The third
group received a comparable volume of olive oil via oral
gavage daily, while the fourth group received 100 mg/kg body
weight per day of gomisin A via oral administration for 4
days. At the fifth day, all animals in the first and second
groups were immediately euthanized using CO2 gas and the
liver samples collected. Meanwhile, the third (CCl4-treated
group, CT group) and fourth groups (gomisin A and CCl4-
treated group, GCT group) received 0.1 mL of CCl4 (Sigma-
Aldrich, St. Louis, MO, USA) solution via intraperitoneal
injection. After 24 hours post-CCl4 injection, these animals
were immediately euthanized using CO2 gas. Liver samples
were collected and stored in Eppendorf tubes at −70
oC until
assayed.
Histological analysis
Liver tissues collected from rats were fixed with 10% formalin
for 12 hours, embedded in paraffin wax, and then sectioned
into 5 µm-thick slices. The liver sections were stained withTranscriptome analysis of the effects of gomisin A 163
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hematoxylin and eosin (H&E, Sigma-Aldrich) and morphological
features were observed under light microscopy (Leica
Mycrosystems, Heerbrugg, Switzerland).
RNA preparation and microarray procedure
Total liver RNA was isolated from rat liver tissue using Trizol
reagent (Invitrogen, Grand Island, NY, USA) according to the
manufacturer’s instructions. The total RNA was dissolved in
diethyl pyrocarbonate-treated distilled water, and stored at
−70
oC. DNA microarray analyses were performed according
to the manufacturer’s standard protocol. Briefly, Cy5-dUTP-
labeled cRNA were prepared from 200 µg of total RNA
isolated from a liver of each group. Complementary RNA
was labeled using a fluorescent cRNA labeling kit (Agilent,
Delaware, DE, USA) according to the manufacturer’s
instructions. Then, 10X blocking agent and ×25 fragmentation
buffer were added to the labeled cRNAs by following the
instructions from the hybridization kit (Agilent). For
hybridization, total cRNAs were applied to a microarray (Rat
44K 4-Plex Gene Expression platform; Agilent) followed by
incubation at 65
oC overnight under humidified conditions.
To control the labeling differences, technical replication was
conducted in which duplicated reactions were carried out
by switching over the fluorescent dyes. Microarray analysis
was performed on using total cRNA hybridization images
captured by a microarray scanner system (G2545CA; Agilent)
using feature extraction (FE) 9.5.3 software at the scanning
resolution of 5 mm.
Analysis of microarray data
Analysis of feature extraction text files produced by the
Agilent scanner and further data evaluations were performed
by using the Genespring GX7.3.1 software package (Agilent
Technologies, Santa Clara, CA, USA). Relative expression levels
of genes were calculated after normalization of the signal
intensity values and outputted with the unigene and genebank
descriptors to a Microsoft Excel data spreadsheet. Gene
ontology (GO) analysis based on biological process and
molecular function ontology analysis was performed using
the web tool Database for Annotation, Visualization, and
Integrated Discovery (DAVID). Kyoto Encyclopedia of Genes
and Genomes (KEGG) biochemical pathways analysis was
also performed by the web tool KEGG (http://www.genome.jp/
kegg/pathway.html).
Results and Discussion
Histological analysis of the rat liver
To investigate the protective effects of gomisin A on CCl4-
induced hepatocellular damage, we examined the histopathology
of livers from all four groups. In the GCT group rat liver,
histological alteration of liver tissue was observed. In both
the UT group (Figure 1A) and GT group (Figure 1B), the
histopathology showed a normal distribution of hepatocytes
with clear visible nuclei, portal triads, and central veins. After
CCl4 treatment, extensive centrolobular necrosis was
observed in and around the central vein of liver (Figure 1C).
However, necrosis was significantly decreased in the liver
section of the group pretreated with gomisin A for 4 days
(Figure 1D). These results suggest that pretreatment with
gomisin A may protect against hepatocellular damage induced
by CCl4 treatment.
RNA preparation and microarray analysis
Preparation of total RNA with high purity is essential for
a successful microarray experiment. The quality of RNA was
measured by Agilent 2100 Bioanalyzer (Agilent). The Agilent
2100 Bioanalyzer provides a platform for the electrophoresis
of nucleic acids on a disposable chip [22,23]. Each RNA
sample (1 mL) was loaded into individual wells on a chip
and electrophoresed in the Bioanalyzer. 18s and 28s ribosomal
peaks were present in all samples by giving RNA Integrity
Numbers (RINs) from 8.0 to 10.0, which indicated the
verification of a good quality of RNA samples for microarray
analysis.
Liver RNA samples from three individual rats were pooled
for each experimental group. Each RNA sample was hybridized
with 41,012 probes on Rat 44K 4-Plex Gene Expression
platform. Systematic errors across all variables in an experiment
Figure 1. Histology of liver tissue. A, vehicle; B, gomisin A
alone; C, carbon tetrachloride (CCl4) alone; D, CCl4+gomisin A.
The hepatocytic morphology on the liver section stained with
hematoxylin and eosin was observed with light microscope at
×400. Arrows indicate the necrotic hepatocytes.164 Young Mi Choi et al.
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can be attributed to well-known sources including biases linked
to the different dyes used at the labeling step. Possible systemic
bias in the data was removed by signal dependent LOWESS
normalization of the MA-plot [24]. This normalized data were
tested for significant gene expression fold changes between
control and samples by a t-test.
Distribution of regulated genes
We identified a number of differentially expressed genes
in the GCT group. In total, the expression of 2,305 genes
was up-regulated more than two-fold (>2), while the
expression of 875 genes was down-regulated more than two-
fold (<0.5). To narrow down the number of genes that are
possibly involved in gomisin A-induced recovery from CCl4-
induced injury, a selection strategy (Figure 2) was employed,
and finally, 255 up-regulated and 230 down-regulated genes
were selected. The up-regulated 255 genes were the genes
that showed increased expression level (>2) after the
treatments in the GCT group, but showd a decreased
expression level in both the GT group (<2) and CT group
(<1). The down-regulated 230 genes were the genes for
which expression level were decreased (<0.5) in GCT group
but were not significantly decreased in either the GT group
(>0.5) or the CT group (>1) compared to the UT group
(Figure 2).
Hierarchical cluster analysis of 488 selected genes resulted
in Clusters I and II, which comprise 255 and 230 genes
that were up- or down-regulated, respectively, by the treatment
of gomisin A on the rat liver damaged by CCl4. A closer
relation was observed between the GT group and GCT group,
indicating that many genes influenced by gomisin A treatment
Figure 2. Dendrograms showing strategies for identifying specifically regulated genes in the process of gomisin A-induced
recovery of rat liver tissues; 255 up-regulated (A) and 230 down-regulated (B) genes were identified. In A, <1 (in CT) and <2 (in GT)
indicate the number of genes that did not showed significant up-regulation in CT and GT groups, respectively, and >2 (in GCT)
indicates the number of genes that showed significant up-regulation in GCT group. In B, >1 (in CT) and >0.5 (in GT) indicate the
number of genes that did not showed significant down-regulation in CT and GT treated groups, respectively, and >0.5 (in GCT)
indicates the number of genes that showed significant down-regulation in GCT group.
Figure 3. Hierarchical clustering of 488 genes selected as
shown in Figure 1. Y-axis shows the list of genes and X-axis
shows control and samples. Red fields show un-regulation of
genes (absolute difference) and green fields show down-
regulation of genes. U, UT group; C, CT group; G, GT group;
GC, GCT group.Transcriptome analysis of the effects of gomisin A 165
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on the normal liver may be associated with recovery from
the liver damage induced by CCl4 (Figure 3).
Among 488 up- or down-regulated genes, 26 genes that
were high ranked in the fold change are listed in Table 1.
A majority of up-regulated genes were related to cell cycle.
These genes included histone deacetylase, which removes
acetyl groups and leads to the compaction
 of chromatin and
DNA silencing. Histone deacetylase has been shown to be
recruited by the retinoblastoma protein (Rb) and related pocket
proteins to the promoters of several cell cycle genes. Thus,
the histone deacetylase gene has been implicated in controlling
the transcription of core cell cycle regulators [25,26]. Up-
regulated genes involved chromatin assembly factor (CAF)
as well. CAF is essential for normal cell cycle maintenance.
CAF1 loss of function in mammalian cells leads to the
activation of a DNA-damage signaling pathway that slows
down the S-phase of cell division and arrests the cell cycle
[27]. E2F is also involved in cell cycle maintenance [28]. Most
of the down-regulated genes were related to focal adhesions
and cell death. These genes included thrombospondin (TSP),
which is a member of a group of extracellular matrix (ECM)
proteins. When exposed to cells in its soluble form,
thrombospondin has primarily anti-adhesive effects
characterized by a reorganization of stress fibers and loss of
focal adhesion plaques as ascertained by interference reflection
microscopy [29-31]. Down-regulated genes also included ADP
ribosyltransferase (ADPRT). ADPRT activity interferes with
eukaryotic DNA synthesis and endocytosis and causes
cytotoxicity and cell death of mammalian cells [32,33].
GO and KEGG biological pathway analysis
Gene ontology and biological pathway analysis were
Table 1. The list of genes identified by the analysis shown in Figure 2. Only the 26 genes that were high ranked in the fold change
and/or assigned in the pathway based on KEGG are shown (Figure 4). The genes involved in the cell cycle pathway or TGF-β
signaling pathway were indicated by 
C, or 
T, respectively
Genbank Description Fold-change t-test
P-value
Up-regulated genes
XM_342149
 C histone deacetylase 2 38.720 0.50 
XM_222932 exonuclease 1 (predicted) 10.110 0.00 
NM_001024741 chromatin assembly factor 1, subunit B (p60) 7.69  0.11 
XM_218601 E2F transcription factor 8 7.12  0.03 
NM_177931
 C  origin recognition complex, subunit 1-like (S. cerevisiae) 6.95 0.13 
XM_226316
 C  minichromosome maintenance deficient 5, cell division cycle 46 (S. cerevisiae) 
(predicted) 6.81 0.01 
XM_213587
 C  similar to cell division cycle 45 homolog (S. cerevisiae)-like 6.15 0.03 
NM_171992
 C cyclin  D1 2.76 0.29 
NM_133571
 C  cell division cycle 25 homolog A (S. pombe) 2.18 0.04 
XM_216161
 C  MAD2 (mitotic arrest deficient, homolog)-like 1 (S. cerevisiae) (predicted) 2.19  0.27 
XM_230765
 C  E2F transcription factor 1 3.59  0.34 
XM_344135
 C  minichromosome maintenance deficient 6 (MIS5 homolog, S. pombe)
(S. cerevisiae) 4.62 0.17 
XM_232168
 C  minichromosome maintenance deficient 2 mitotin (S. cerevisiae) (predicted) 2.53  0.25 
Down regulated genes
NM_001017496 similar to small inducible cytokine B13 precursor (CXCL13) (B lymphocyte 
chemoattractant) (CXC chemokine BLC) 0.05 0.14 
XM_342172
T thrombospondin 4 0.17  0.22 
AB002393 histidine ammonia lyase 0.20  0.24 
NM_001013228 T-complex associated-testis-expressed 1-like (Protein 91/23) 0.22  0.26 
NM_012533 carboxypeptidase B1 (tissue) 0.23  0.25 
NM_001012034 ADP-ribosyltransferase 3 0.23  0.26 
XM_235330 collectin sub-family member 10 (C-type lectin) (predicted) 0.24  0.26 
XM_224757 similar to chondroitin beta1,4 N-acetylgalactosaminyltransferase (predicted) 0.25  0.29 
NM_001012187 kelch-like 7 (Drosophila) 0.26  0.27 
XM_343410 PREDICTED: Rattus norvegicus similar to MEGF11 protein (LOC363079), 
mRNA [XM_343410] 0.26 0.27 
XM_214778
 T thrombospondin  2 0.41  0.36 
XM_217409
 T  bone morphogenic protein receptor, type II (serine/threonine kinase) 0.44  0.50 
NM_019191
 T  MAD homolog 2 (Drosophila) 0.46  0.58 166 Young Mi Choi et al.
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performed with the genes selected as being specifically
regulated in the process of gomisin A-induced recovery of
rat liver tissues. Among 255 up-regulated and 230 down-
regulated genes, 110 and 141 genes with Entrez gene IDs
were matched to genes in Rattus norvegicus, respectively.
These genes were further analyzed for functional classification
by GO term and pathway assignment by KEGG.
The most statistically significantly represented GO terms
are displayed in Table 2. “Nucleic acid metabolism and cell
cycle” was identified as the most significantly related biological
process to the up-regulated genes. For down-regulated genes,
“oxidoreductase and dehydrogenase” were identified as the
most significantly related molecular functions. Oxidoreductases
belong to a family of genes that are involved in the regulation
of programmed cell death. Oxidoreductase mediates cell death
caused by the novel anti-cancer drug β-lapachone [34]. Also,
dehydrogenase causes a programmed cell death in ERK kinase
signaling events [35].
Biological pathway assignment based on KEGG was
displayed in Table 3. “Cell cycle” (Figure 4A) was identified
by up-regulated genes as the most statistically significant
pathway, which was in accordance with the result of GO
term analysis. While the majority of up-regulated genes were
related to cell cycle in the distribution of regulated genes,
focal adhesion, ECM-receptor interaction, and TGF-beta
signaling pathway (Figure 4B) were identified as the most
statistically significant in down-regulated genes. A single CCl4
administration can cause hepatic injury that is associated with
ECM accumulation. During the remodeling process of the
liver architecture from hepatic damage, including inflammation,
fibrosis and regeneration, TGF-β1 plays a pivotal role in
stimulating the liver [36]. Initiation of hepatic fibrosis starts
with paracrine stimulation of injured hepatocytes and
endothelial cells, as well as subtle changes in ECM composition
[37]. They produce pro-fibrogenic cytokines such as TGF-
β. TGF-β as a major fibrogenic cytokine is heavily involved
in abnormal ECM accumulation by increasing the synthesis
of ECM components [38]. ECM molecules bind to integrin
cell surface receptors and activate downstream focal adhesion
molecules involved in the regulation of anchorage-dependent
cell growth, proliferation, survival, differentiation, morphology,
migration, and death [39,40]. Especially, liver fibrosis is
characterized by excessive deposition of ECM, which leads
to a severe pathological disturbance in the liver. During liver
Table 2. Functional classification of 251 selected genes based on statistically significant represented GO terms
Category Term Count % P-value
Up-regulated genes 　　　
Biological
process
Nucleoside, nucleotide and nucleic acid metabolism 26 23.64 0.01
Cell cycle 19 17.27  1.55E-06
DNA metabolism 11 10.00  6.98E-06
Cell proliferation and differentiation 11 10.00 0.02
Cell cycle control 9 8.18 0.001
DNA replication 8 7.27 5.63E-06
Chromatin packaging and remodeling 4 3.64  0.08
Down-regulated genes
Molecular
function
Oxidoreductase 10 7.09 0.06
Dehydrogenase 8 5.67 0.001
Actin binding cytoskeletal protein 7 4.96  0.05
Ligase 7 4.96 0.08
Table 3. Pathway assignment of 251 selected genes based on KEGG
Term Count % P-value
Up-regulated genes 　　 　
Cell cycle 10 9.09 3.33E-07
DNA replication 3 2.72 0.0292932
Pancreatic cancer 3 2.72 0.0981716
Down-regulated genes
Focal adhesion 8 5.67 0.001
ECM-receptor interaction 4 2.83 0.03
TGF-beta signaling pathway 4 2.83 0.04
Valine, leucine, and isoleucine degradation 3 2.12 0.06
Vascular smooth muscle contraction 4 2.83 0.08Transcriptome analysis of the effects of gomisin A 167
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Figure 4. Pathway assignment of the important genes based on KEGG. The genes of up-regulation in cell cycle pathway (A) and
the genes of down-regulation in TGF-β signaling pathway (B) were determined by KEGG pathway. The genes found in our
microarray analysis were labeled by star symbols.168 Young Mi Choi et al.
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fibrogenesis, an increase in TGF-beta activity has been reported
[41]. TGF-beta is an important cytokine in regulating the
production of ECM for liver fibrosis [42,43].
In conclusion, our histological observation showed that
gomisin A treatment could repair the rat liver with CCL4-
induced damage. Further, our microarray experiment
indicated that the liver repair mechanism induced by gomisin
A was strongly associated with increased expression of genes
related to cell cycle and suppression of the genes involved
in cell death mediated by the TGF-β pathway.
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